As for melanoma-specific survival (MSS) and overall survival (OS), NECTIN4-high patients tended to show shortened survival (p = 0.196 for MSS and p = 0.0733 for OS) (Figure 1c,d). The gene discussed is NECTIN4; the disease is melanoma.